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During the course of a viral infection, viral proteins
interact with an array of host proteins and pathways.
Here, we present a systematic strategy to elucidate
the dynamic interactions between H1N1 influenza
and its human host. A combination of yeast two-
hybrid analysis and genome-wide expression pro-
filing implicated hundreds of human factors in medi-
ating viral-host interactions. These factors were then
examined functionally through depletion analyses in
primary lung cells. The resulting data point to poten-
tial roles for some unanticipated host and viral
proteins in viral infection and the host response,
including a network of RNA-binding proteins, com-
ponents of WNT signaling, and viral polymerase
subunits. This multilayered approach provides a
comprehensive and unbiased physical and regula-
torymodel of influenza-host interactions and demon-
strates a general strategy for uncovering complex
host-pathogen relationships.
INTRODUCTION
Mammalian cells have developed complex systems to detect
and eliminate viral pathogens, while viruses have evolved mech-
anisms to co-opt host processes and suppress host defenses.
For example, influenza A is a segmented, single-stranded, nega-
tive-sense RNA virus that has adapted to infect multiple species.
Upon infection by influenza, host cells detect viral RNA through
pathogen sensors, such as RIG-I, and induce type I interferons
(IFNs) and an antiviral program that is common to many RNACviruses (Figure 1A) (Takeuchi and Akira, 2009). At the same
time, the ten major (and one minor) gene products of influenza
virusmediate the viral life cycle andmodulate cellular processes.
Most notably, the NS1 protein subverts host defenses through
several mechanisms, including suppression of RIG-I/TRIM25-
mediated sensing of viral RNA (Gack et al., 2009; Pichlmair
et al., 2006), PKR antiviral activity (Li et al., 2006), and cellular
mRNA processing (Krug et al., 2003). Immune regulatory func-
tions for the other influenza proteins have yet to be defined,
as their assigned roles have been limited to viral entry into cells,
viral RNA trafficking, replication, and transcription, as well as
assembly of mature virions. Similarly, the function of the vast
majority of host factors remains unexplored. Previous studies
on viral and host factors have focused on specific interactions
but have not produced global models of the viral-host relation-
ship, with few exceptions (Brass et al., 2008; Bushman et al.,
2009; Ko¨nig et al., 2008; Krishnan et al., 2008; Li et al., 2009).
Here, we use an integrative functional genomics strategy (Fig-
ures 1B–1D) to generate a draft model of influenza-host interac-
tions for the H1N1 strain A/PR/8/34 (‘‘PR8’’). Our experimental
and computational approach uncovers host networks contacted
by viral proteins, cellular transcriptional responses to infection,
and functional roles for candidate factors in influenza-infected
primary lung epithelial cells. We integrate these datasets to
generateaphysical, regulatory, and functionalmap that implicates
hundreds of host factors in the influenza-human relationship.RESULTS
Identification of a Human Protein Network
that Physically Interacts with Ten Viral Proteins
To identify host factors that may participate in the pathogenesis
of influenza infection, we first sought to identify those factors thatell 139, 1255–1267, December 24, 2009 ª2009 Elsevier Inc. 1255
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Figure 1. Integrative Strategy to Generate a Physical, Regulatory, and Functional Map of Influenza-Host Interactions
(A) When influenza infects host cells, viral components, including viral RNA (vRNA) and viral proteins, interact with host proteins to induce changes in host gene
expression and cellular functions. The RIG-I sensor detects virus-derived RNA and regulates host gene expression, including IFNb, which in turn activates an
antiviral program through the interferon receptor (IFNR). We distinguish viral-regulated genes (VRGs, orange), affected by infection, RNA-regulated genes
(RRGs, green), affected directly by vRNA, and interferon-regulated genes (IRGs, yellow), affected directly by interferon treatment. NS1 is known to inhibit the
RIG-I response.
(B–D) A genomic strategy to deconstruct influenza-host interactions. Host proteins that physically interact with each of the ten viral proteins are identified with
a systematic yeast two-hybrid approach (B), and arrays are used to define the transcriptional responses of primary human bronchial epithelial cells (HBECs) to
components of the virus and to virus infection (C). The physical and transcriptional maps were used to computationally predict human factors and pathways that
affect the viral life cycle or host response.We tested these predictions by perturbing each gene andmeasuring the effect on IFN production and viral replication in
primary HBECs (D).are directly manipulated through physical associations with viral
proteins. We used a yeast two-hybrid (Y2H) approach to system-
atically identify direct binary contacts among the ten major viral
proteins of the PR8 strain, as well as between each viral protein
and each of 12,000 human proteins available in the Human
ORFeome v3.1 collection (Lamesch et al., 2007). We discovered
31 intraviral interactions (out of 55 possible interactions,
including homodimers) among the ten viral proteins (Figure 2A,
Table S1 part A available online), and 135 pairwise interactions
between the ten viral proteins and 87 human proteins (‘‘H1’’
genes, Figure 2B, Table S1 part B), 73 of which are expressed
in primary human bronchial epithelial cells (HBECs). These
included the previously reported association between NS1 and
STAU1, interactions between NS1 and PRKRA and TARBP2
(regulators of PKR-mediated transcription; for a review of NS1-
host interactions, see Hale et al. [2008]), and interactions
between influenza and eight proteins that are targeted by other1256 Cell 139, 1255–1267, December 24, 2009 ª2009 Elsevier Inc.viruses (Table S1 part B). Several known associations were not
observed, either because the interacting protein was not among
the 12,000 proteins in our assays (e.g., TRIM25 [Gack et al.,
2009] and DDX58/RIG-I [Pichlmair et al., 2006]), or for unknown
reasons (e.g., we did not detect the PKR-NS1 interaction
[Li et al., 2006], yet we identified the kinase that phosphorylates
PKR).
The connectivity pattern of the intraviral and viral-human
network revealed three important principles. First, the influenza
intra-viral network is extremely interconnected (Figure 2A, Table
S2 part A), consistent with findings from other viruses (Bailer
and Haas, 2009). This may be required for forming compact
virions and functional viral complexes. Second, influenza
proteins interact on average with a significantly greater number
of human proteins than expected from the human interaction
network (13.5 versus 6.5 expected, p < 0.06, permutation test),
even when compared to other viruses (Table S2 part A), or
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Figure 2. A Map of Viral-Human Protein
Interactions Identifies a Dense Intercon-
nected Network, Coupled to Key Cellular
Signaling Pathways
(A) Viral-viral interactions. Green nodes, viral
proteins; edges, direct physical interactions
observed in a Y2H assay.
(B) Influenza-human interactions. One hundred
and thirty-four interactions (edges) connect the
ten influenza proteins (green nodes) to 87 ‘‘H1’’
human proteins. Yellow fill, RNA-binding proteins;
blue fill, protein transport; red border, transcription
factors; red fill, 30 proteins that play a role in four
major signaling pathways (NFkB, apoptosis,
MAPK, and WNT signaling); white fill, proteins
with other functions.
(C) Thirty host interactor proteins (H1) are shown
with their membership in specific pathways (red)
or direct interactions with influenza proteins (light
green). H1 proteins are either known components
or have established interactions with components
of these pathways (see the Experimental Proce-
dures). Many of the 30 proteins are involved in
multiple signaling pathways, and interact with
polymerase subunits. Influenza A proteins: PB1,
PB2, and PA (viral polymerase subunits); NP
(nucleocapsid protein), involved in viral RNA trans-
port, packaging, and polymerase functions; HA
(hemagglutinin) mediates entry; NA (neuramini-
dase) aids in release of viral particles; M1 (matrix protein) mediates export and assembly of RNA and viral particles; M2 (matrix protein) modulates fusion through
its proton channel activity; NS1 (nonstructural protein) regulates host pathways; and NS2 (nonstructural protein), involved in RNA export.when comparing to the full 12,000 prey human network (data not
shown). This may reflect the fact that a virus has to maximize the
diversity of functions per protein. Third, some of the human
proteins contact a greater than expected number of influenza
proteins (24 human proteins interact with at least two flu
proteins, p < 105, permutation test, Figure 2B, Table S2 part B).
Thesemay be required for the formation of viral-hostmultiprotein
complexes.
The H1 proteins form interconnected hubs within the cellular
protein network, suggesting that the virus targets proteins that
play a central role in their respective cellular pathways. The
87 H1 proteins connect with each other through 51 interactions
and with other human proteins (first neighbors; ‘‘H2’’ genes)Table 1. Network Parameters of Influenza and Cellular Protein Inte
Network Parameters All-H1 All-H1H2 PB1-H1 PB2-H1 PA-H1 NP-
Nodes 87 653 23 32 21 12
Total edges 2768 17,106 1312 1640 156 686
Average Degree 34.4 30.6 60.0 55.4 8.2 57.3
Stdev Degree 42.9 43.6 50.3 49.6 7.7 36.2
Median Degree 17 15 53 47 5 59
The parameters in this table quantify the numbers of interactions between
interaction network (see the Experimental Procedures). For example, there
that interact with 2768 human proteins with an average of 34.4 interactions
the 87 H1 proteins and 566 H2 proteins that interact with them based on cura
protein X.
Cthrough 2717 interactions, a higher than expected connectivity
(p < 105, permutation test). The higher density of interactions
is observed even when excluding the most highly connected
H1 proteins, or when considering only the H1 proteins associated
with individual viral proteins (Table 1).
Furthermore, we identified a core cellular subnetwork that is
enriched for H1 proteins (p < 0.05-10
4, hypergeometric test;
Experimental Procedures, Table S3). This subnetwork contains
six H1 proteins that bind at least three other H1 proteins (e.g.,
TRAF2, DVL2, and FXR2) and 37 non-H1 proteins that fit the
same criteria (e.g., p53, PKR, ILF3, and PSMF1, none of which
contacts any viral protein directly). The network (Figure S1)
consists of diverse proteins including RNA-binding proteins,raction Networks
H1 M1-H1 M2-H1 NS1-H1 NS2-H1 HA-H1 NA-H1 H. Sapiens
11 9 20 2 3 2 11,624
378 384 549 50 9 11 57,206
37.8 48.3 32.5 9.9
40.6 48.7 47.1 19.9
31 32 17 4
a defined set of proteins (one set in each column) with the entire human
are 87 H1 proteins (i.e., direct interactors with the 10 PR8 viral proteins)
per H1 protein (with standard deviation of 42.9). The All-H1H2 set includes
ted associations. X-H1 consists of the direct human interactors of the viral
ell 139, 1255–1267, December 24, 2009 ª2009 Elsevier Inc. 1257
regulators of ubiquitination and sumoylation, transcription fac-
tors, mediators of apoptosis, and components of immune
signaling pathways (Figures 2B, 2C, S1 and S2).
Our observations also hold in another influenza strain, the
H3N2 A/Udorn/72 influenza virus (‘‘Udorn’’). Using the same
Y2H approach, we detected 81 interactions between ten Udorn
viral proteins and 66 human proteins. Of these, 56 human
proteins also interact with PR8 (p < 1010, hypergeometric
test; Table S1 part C and Figure S3A), including most RNA-
binding proteins, regulators of transcription, protein transport,
and signaling (Figure S3B). For example, out of 30 signaling
proteins and 19 transcription factors that directly interact with
PR8 (Figures 2B and 2C), 28 and 16 proteins (respectively) also
directly bind to Udorn proteins (Figure S3B). Most (63%) of the
H1 proteins that were associated with PR8 NS1, NP, or the poly-
merase subunits (PB1, PB2, PA) were also found to interact with
their counterparts in the Udorn strain (Figure S3C and Table S1
part B), reflecting conserved functions of viral proteins.
Viral Proteins Interact with the NF-kB, Apoptosis,
and WNT Pathways Primarily through NS1
and Polymerase Subunits
To identify the key cellular pathways coupled to the virus, we
considered the 87 H1 and 566 H2 cellular proteins from a manu-
ally curated database (IPA) and found that they are enriched for
components of several signaling pathways (Table S4 part A,
Figure 3D; see the Experimental Procedures). Thirty of the 87
H1 interactors couple the virus to six major pathways, including
p53-, PML- and TNFR/Fas-mediated apoptosis, NF-kB, and
WNT/b-catenin (Figure 2C). The interactions with these path-
ways are conserved for the Udorn strain (Figure S3C), sug-
gesting that the discovered interactions reflect a generalized
strategy of influenza tomanipulate the host. A role for these path-
ways in viral infections has been described (e.g., p53, Turpin
et al. [2005]), yet their direct physical association with influenza
proteins was not previously reported.
While NS1 is considered the major viral protein to modulate
host signaling, we found that 26 of the 30 H1 proteins associated
with these pathways interact with viral polymerase subunits and
NP, but only eight interact with NS1 (Figure 2C). In particular, H1
andH2 interactors of PB1, PB2,NPare highly enriched (p<10
10,
Fisher’s combined probability test) for the six key pathways,
but those of PA are not (Figure 3D; this result also holds for
Udorn, Figure S3C). This suggests that viral polymerase proteins
may also act as direct modulators of host signaling pathways.
Expression Profiling of the Response to Viral Infection
in Primary Human Lung Epithelial Cells
We next defined the major transcriptional responses in primary
HBECs after either infection with influenza or treatment with rele-
vant ligands. We used four different strategies, each highlighting
distinct components of the response: (1) We infected cells with
the wild-type PR8 influenza virus that can mount a complete
replicative cycle. (2) We transfected cells with viral RNA (vRNA)
isolated from influenza particles. This does not result in the
production of viral proteins or particles and identifies the effect
of RNA-sensing pathways (e.g., RIG-I.). (3) We treated cells
with interferon beta (IFNb) to distinguish the portion of the1258 Cell 139, 1255–1267, December 24, 2009 ª2009 Elsevier Inc.response that is mediated through type I IFNs. (4) We infected
cells with a PR8 virus lacking the NS1 gene (DNS1). The NS1
protein normally inhibits vRNA- or IFNb-induced pathways,
and its deletion can reveal an expanded response to infection.
We could not assess the role of any other viral protein but
NS1, since deletion strains cannot be propagated easily (Wress-
nigg et al., 2009). For each of the four stimuli, we profiled the
cellular transcriptional response at ten time points (0.25, 0.5, 1,
1.5, 2, 4, 6, 8, 12, and 18 hr) in duplicate experiments.
Transcription Patterns Distinguish Interferon-,
RNA- and Virus-Responsive Genes
We found 12 major temporal and functional patterns of gene
expression (C1–C12, Figures 3A and 3B), each associated with
at least one stimulus, and covering 1056 genes that were all
regulated in response to viral infection (virus-regulated genes
[VRGs]). Among these, we found 666 interferon-regulated genes
(IRGs) that are affected by interferon directly (325 induced,
C1–C4, and 341 repressed, C9–C10, Figures 3A–3C). All of the
IRGs are similarly affected by vRNA transfection and DNS1 virus
but with an observed time delay, likely due to the induction of
IFNb by these stimuli. PR8 infection induces IRGs to a much
lower level (with few exceptions, C2, 57 genes), and abrogates
the downregulation of 49 IRGs (C9). This is consistent with the
known role of NS1 in dampening RNA sensing and downstream
interferon production (Pichlmair et al., 2006) (Figure S4).
Next, we found 721 RNA-regulated genes (RRGs) that are
directly modulated by transfected vRNA (380 induced, C1–C5;
341 repressed, C9–C10, Figures 3A–3C). All of the RRGs are
similarly affected by DNS1 virus infection, while 171 are regu-
lated by PR8 infection. Thus, viral RNA present in the infecting
virion and produced during modest viral replication (as with
DNS1 virus) can induce a potent response. Induced RRGs
(C1–C5) were enriched for antigen presentation, apoptosis,
NFkB and IRF signaling (p < 104–1017; hypergeometric test,
Figure 3D).
Most of the induced RRGs are also induced by interferon treat-
ment (C1–C4, 325 of 380), but a few IFNb-independent RRGs (C5)
are induced only by vRNA and DNS1 virus. These include impor-
tant antiviral genes (e.g., IFNB1, IL7R, ING3, IRF2, and PELI1)
and are enriched for TLR pathway components, cytokines, che-
mokines, and cell cycle and apoptosis (p < 103, Figure 3D). An
IFNb-independent mechanism (e.g., IRF3-dependent based on
promoter sequence analysis, data not shown) is likely to mediate
the transcription of these genes.
Finally, we identified virus-specific response genes (VSRGs)
that are transcriptionally regulated after PR8 orDNS1 virus infec-
tion, but not after vRNA transfection or IFNb treatment (C6–C8
and C11–C12). Sixty-eight VSRGs are induced only by DNS1
(C6) and are enriched for regulators of apoptosis and NFkB
(e.g., BCL10, TRAF6, NFKB1, and NFKBIE). NS1 may block their
induction and dampen the NFkB pathway by an unknown RNA-
and IFN-independent mechanism. Sixty VSRGs are induced by
both PR8 and DNS1 (C7) and are enriched for regulators of
apoptosis, cell cycle, and transcription factors (p < 103,
Figure 3D). Finally, 31 VSRGs (C8) are induced only by PR8,
possibly directly by NS1 or as the result of the higher burden of
a replicating virus.
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Figure 3. Distinct Transcription Patterns of Interferon-, RNA-, and Virus-Responsive Genes
(A and B) Gene expression changes in HBECs in response to IFNb (IRGs, yellow bar), vRNA (RRGs, green bar), wild-type influenza (PR8) and mutant DNS1 virus
(VRGs, orange bar; genes differentially regulated by NS1, brown bar) at ten time points (0.25, 0.5, 1, 1.5, 2, 4, 6, 8, 12, and 18 hr, tick marks). Genes that were
upregulated (A, red) and downregulated (B, blue), relative to the expected level from mock-treated cells, were grouped into 12 clusters (C1–C12). Left columns
denote gene membership in five major functional categories (black lines, category is enriched in cluster; gray lines, category is not enriched in cluster).
(C) Venn diagrams indicate number of members in each class of regulated genes and their dependence on NS1 (bottom), within the subset of upregulated (left)
and downregulated (right) genes.
(D) Functional and pathway annotation of expression clusters and interaction neighborhoods. Shown are the functional categories and pathways (rows) enriched
in each of the 12 expression clusters (red, left matrix) and interaction neighborhoods (H1 and H2) of each viral protein (blue, right matrix). The bottommatrix shows
the significant overlaps (purple) between expression clusters (1–12, rows) and viral neighborhoods (columns).
(E) Enrichment analysis identifies pathways that are overrepresented in the influenza physical network (ten pathways, blue) and in transcriptional responses
(14 pathways, red), with an overlap of seven pathways enriched in both (purple, p < 3.5 3 107). Pathways chosen for functional follow-up assays are colored
in green.
Cell 139, 1255–1267, December 24, 2009 ª2009 Elsevier Inc. 1259
NF-kB, MAPK, and Apoptosis Pathways Are Regulated
through Both Transcriptional and Physical Interactions
Some of the host systems affected at the transcriptional level
by viral infection may be linked to the virus through physical
interactions. Indeed, we found that the cellular network of direct
interactors (H1) and first neighbors (H2) is enriched for genes that
are transcriptionally regulated upon viral infection (70 of 1056
VRGs, p < 4 3 104, hypergeometric test). For example, the
NS1 neighborhood is enriched in C6 (p < 0.01), a VSRG cluster
induced only in response to infection with DNS1 virus (e.g.,
NFKB1, BCL10). Similarly, the neighborhood of the polymerase
subunit PB2 and NP is also enriched in C6 (p < 73 10
4), further
supporting the potential role of the viral polymerase in modu-
lating host pathways in concert with NS1.
While some cellular pathways are uniquely associated with
either the physical network (e.g., WNT, Ras/Rho) or transcrip-
tional responses (e.g., type I IFN and antigen presentation),
many are enriched for both (p < 3.5 3 107, hypergeometric
test, Figures 3D and 3E). These include p53-mediated apo-
ptosis, PML, NFkB, MAPK, and p38 signaling. These pathways
are mostly associated with rapidly and highly induced IRGs
(C2) or VSRGs that are inhibited by NS1 (C6). Thus, the virus
physically engages critical pathways while inducing transcrip-
tional changes in their components.
Functional Interrogation of Viral Interactors
and Transcriptionally Responsive Genes
The physical interactions, transcriptional responses, and associ-
ated pathways together identified 1745 candidate genes that
could impact influenza infection. These included 1056 genes
that were transcriptionally regulated, 259 direct interactors and
their first neighbors (H1/H2) (67 of them are also transcriptionally
regulated), and 504 further candidates predicted from our anal-
yses (e.g., pathway members) that are expressed in HBECs.
To test the functional contribution of these genes to viral
replication and type I IFN production, we measured the effect
of perturbing each gene using targeted small interfering RNA
(siRNA) pools in three functional assays. In the viral replication
assay, we infected siRNA-transfected primary HBECs with
PR8 virus and measured virus production after 48 hr using a
cellular reporter system that is analogous to conventional
plaque assays (Experimental Procedures). In two independent
assays, we used a reporter cell line to measure levels of IFNb
in siRNA-transfected HBECs in response to DNS1 virus infection
or vRNA transfection.
We determined the relative effect of each of the 1745 siRNA
pools in each assay using a statistical scoring approach (Exper-
imental Procedures) that identifies significant changes in pheno-
types relative to the background of all tested genes. Since we
selected a focused set of candidates for functional testing, this
scoring approach is highly conservative. Furthermore, because
cell number impacts production of IFN, we used AlamarBlue to
determine cellular viability following siRNA knockdown and to
effectively normalize IFN values to the number of cells in each
well. We used a 2-fold threshold (Experimental Procedures) to
identify genes whose perturbation significantly impacted the
phenotypes evaluated in each of the three assays, distinguishing
positive and negative regulators of each phenotype.1260 Cell 139, 1255–1267, December 24, 2009 ª2009 Elsevier Inc.Six hundred and sixteen of the 1745 candidate genes affected
at least one of the phenotypes significantly. The number of genes
with two or more significant phenotypes is substantially higher
than expected by chance (p < 104, permutation test, Fig-
ure S5). These included all themajor sources of candidate genes,
including 361 transcriptionally responsive genes, 88 direct inter-
actors (H1) and first neighbors (curated H2), and 174 additional
members of identified pathways. This suggests that many of
the transcriptional and physical target pathways play an impor-
tant role in infection.
Distinct Functional Signatures for Regulators of IFN
Production and Viral Replication
We divided the 616 validated genes into 20 ‘‘phenoclusters’’ on
the basis of the combinatorial behavior of each gene across the
three functional assays (Figure 4A). vRNA-dependent regulators
of IFNb production are members of phenoclusters in which IFNb
levels changed in response to vRNA (211 positive regulators,
P1–6; 145 negative regulators, P7–12). These genes correctly
includemanywell-known regulators of type I IFN, both activators
(e.g., VISA, IRF3, RELA, IkBKg, IkBK3, IkBKb, and IRF9) and
repressors (e.g., PTPN6 and IRF2). Knockdown of some of these
genes did not affect PR8 replication (P1,2,7,8. e.g., IFNb in P1),
probably because the NS1 protein already ensures low levels
of IFNb postinfection. Others (P3,4,9,10, e.g., IRF3 and IRF2) had
opposing effects on IFN levels and viral replication, including
genes (P4,10) that were essential for IFNb-dependent antiviral
effects even in NS1-inhibited cells. Genes that were not previ-
ously known to affect IFN production included a potential ubiq-
uitin ligase complex (CUL1 and FBXO34), regulators of vesicle
trafficking (e.g., CHMP6 and ARL4A), peroxisomal components
(PEX14), WNT pathway genes (below), and genes known to be
involved in the life cycle of other viruses (e.g., TMF1 binding to
the HIV TATA element (Table S5) (Garcia et al., 1992).
Virus-dependent, vRNA-independent regulators of IFNb pro-
duction (137 genes, P13–14, P17–20) affect DNS1-induced, but
not vRNA-induced, IFN production. These are subdivided into
genes that do not affect (P13,14), inversely affect (P19,20), or
concordantly affect PR8 replication (P17,18; we cannot rule out
the possibility that these genes affect IFN production as a conse-
quence of their effect on replication). These genes include
PRKRA, a known regulator of PKR (in P20) and TRAF6 (in P13),
known essential regulators of PR8 replication such as NXF1
(P17) and PGD (P17) (Hao et al., 2008; Satterly et al., 2007), and
inflammasome-associated components (NOD2 and NLRP9,
P18), consistent with recent findings (Sabbah et al., 2009). We
also observe candidates such as TTC12 (P18) that associates
physically with PB1 (Figure 2B). PKR, a known repressor of viral
replication, is also a member of this group (P14) and shows no
effect on PR8 replication in our assay. This probably reflects
masking of PKR activity by the NS1 protein (Li et al., 2006), sug-
gesting that other regulators of viral replication masked by NS1
are members of this class.
IFN-independent regulators of viral replication (107 genes,
P15–P16) are genes that affected PR8 replication, but did not
affect IFN production. These include PML, an ‘‘H2’’ gene and
a well-established negative regulator of viral replication (Everett
and Chelbi-Alix, 2007), and a previously unappreciated negative
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Figure 4. Functional Interrogation and Classification of Candidate
Genes Identified through Integrative Analysis of Influenza-Human
Interactions
(A) Classification of phenotypes resulting from siRNA-mediated knockdown of
616 genes. The heat map shows phenotype scores corresponding to three
functional assays (columns) performed on HBECs after transfection with
siRNAs (rows). Gene phenotypes are hierarchically clustered, resulting in 20
major phenoclusters (P1–20). NS1 (IFN), assay for production of interferon after
infection with DNS1 virus; vRNA (IFN), assay for production of interferon after
transfection with viral RNA; PR8 (Replication), assay for infectious virion
production after infection with PR8 virus. Yellow, positive regulator (lower
IFN or virus titer); purple, negative regulator (higher IFN or virus titer). Selected
genes (also referred to in the main text) are marked (left).
(B) Distribution of phenotype scores for direct physical interactors and their
first neighbors. H1/H2 interactors (excluding NS1) show a significantly higher
number of positive regulators of interferon production after infection with
DNS1 (green) compared to vRNA transfection (yellow) (right). There is no
such shift in the distribution for all 616 genes shown in the phenocluster heat
map (left).regulator, USHPB1, that interacts physically with PB1 and PB2
(Figure 2B and Table S1 part B). P15 includes several candidate
positive regulators of replication, including RIOK3, which is
induced only by PR8 virus (C8), and ZMAT4, which interacts
directly with M1/PB1/NS1 (Figure 2B).
We next determined the relative contribution of transcription-
ally regulated genes to each of the phenoclusters. VSRGs that
are induced by both PR8 and DNS1 infection (C7) included
30 genes with effects in our functional assays. This class ofCgenes was enriched in phenotypes (p < 0.007) with (mostly posi-
tive) effects on IFN production in DNS1. The observation that
a wild-type virus and a virus lacking NS1 could induce IFN acti-
vators suggests that cells may possess RIG-I-independent
mechanisms to initiate the antiviral IFN response.
A Subnetwork of RNA-Binding Proteins Affects IFNb
Production during Infection
The functional assays revealed the importance of a number of
densely connected areas of the influenza-cellular interaction
network (Figure S1). One of these areas was enriched for RNA-
binding proteins (p < 104, Figure S1), including the known regu-
lator PKR, and RBPMS, ILF3, FMR1, DHX9, ZNF346, and
HNRPC. ILF3 is phosphorylated by PKR and associates with
XBP-1 (both are key mediators of the stress response [Patel
et al. 1999]), and ILF3 in turn interacts with DHX9 and HNRPC
(Reichman et al., 2003). Since influenza is an RNA virus, this
enrichment may reflect direct regulation of the influenza life
cycle. Indeed, we found that short hairpin RNA (shRNA)-medi-
ated depletion of four of these genes significantly affected inter-
feron production after DNS1 infection (Figure 5A), with two as
negative regulators (PKR and ILF3), and two as positive regula-
tors (DHX9 and HNRPC).
WNT Pathway Components Modulate Cellular
Responses to Infection
Another highly enriched subnetwork involved components of the
WNT signaling pathway. There is a significant number of interac-
tions between influenza proteins and members of the WNT/
b-catenin pathway, and deletion of WNT pathway components
significantly impacts influenza replication and interferon pro-
duction (Figure S6). Consistently, recent studies have implicated
the WNT pathway in the modulation of immune function (Staal
et al., 2008) and in regulating cell survival and proliferation in
EBV infected B cells (Hayward et al., 2006). To test the involve-
ment of the WNT pathway in influenza pathogenesis, we mea-
sured the effect of WNT3a treatment on interferon production
after influenza infection or vRNA transfection. We found that
direct treatment of cells with WNT3a increased IFN production
in both assays (Figures 5B and 5C). The mechanism of action
is yet to be defined.
The Viral Polymerase May Mediate a Non-NS1 Effect
on IFNb Production
The non-NS1 physical interactors and their direct neighbors
(non-NS1 H1/H2) have a higher number of positive regulators of
interferon production in the DNS1 assay than in the vRNA trans-
fection assay (p < 0.001, Kolmogorov-Smirnov test, Figure 4B,
right). This distinction is in marked contrast to the overall simi-
larity in phenotypic effects of all the remaining genes (i.e., 616
non-H1/H2 genes) on IFNb production in both assays (Fig-
ure 4B, left). This suggested that non-NS1 viral proteins partici-
pate in the manipulation of IFN production in response to viral
RNA.
To identify candidate non-NS1 mechanisms that mediate the
effect on IFN production, we ranked each of the viral proteins
based on their neighborhood enrichment for cellular pathways.
The most prominently enriched neighborhoods of non-NS1ell 139, 1255–1267, December 24, 2009 ª2009 Elsevier Inc. 1261
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Figure 5. Functional Roles of an RNA-Binding Protein
Subnetwork, the WNT Pathway, and the Viral Polymerase
(A) RNA-binding proteins play a role in regulating interferon production
in HBECs infected with DNS1 virus. HBECs were infected with lentivi-
ral shRNAs to knockdown each of five candidate RNA-binding
proteins. Cells were selected in puromycin for 5 days and then stimu-
lated with DNS1 virus. Supernatants were collected 24 hr postinfec-
tion, and IFNb protein levels were quantified by ELISA (black bars,
left y axis). In the same experiment, the efficacy of knockdown by
each shRNA on its target mRNA was quantified (gray bars, right y
axis, measured by qPCR relative to GAPDH). (n = 3.)
(B and C) WNT protein potentiates ISRE responses in epithelial cells.
293T-ISRE-luciferase reporter cells were treated with WNT3a for
24 hr and then infected with DNS1 virus or transfected with vRNA
for 18 hr. Luciferase reporter activity (y axis) was quantified in
response to DNS1 infection (B) or transfected vRNA (C) (purified
from PR8 virions). (n = 6.)
(D) Overexpression of viral polymerase subunits or NP and their effects
on ISRE-inducing activity after vRNA transfection. 293T-ISRE-lucif-
erase reporter cells were transfected with an expression plasmid
encoding each influenza polymerase subunit or with combinations of
plasmids (bottom panel) and then stimulated with transfected vRNA.
ISRE responses to transfected vRNA were quantified for each of
PB1, PB2, NP, PA, NA, control GFP, and their combinations. Similar
results were obtained when cells were infected with DNS1 virus
(data not shown). Significant effects of overexpression were found
only for PB1, PB2, NP, and PB1/PB2/NP/PA versus NA (but only
two are marked for clarity). (n = 6.)
Error bars represent the standard deviation of the replicates. *p < 0.05
(t test).proteins were for two of the three viral polymerase subunits (PB1
and PB2) and NP (Table 1, Figure 3D). These neighborhoods are
also conserved in the Udorn strain (p < 1010, hypergeometric
test), and are enriched for VSRGs (C6) whose expression is
induced only in DNS1 infection. We thus hypothesized that the
viral polymerase may play a previously unappreciated, NS1-
independent, role in modulating interferon production.
To test this hypothesis, we measured the effect of overex-
pressing viral-polymerase subunits and NP on cellular produc-
tion of IFN. Indeed, we found that overexpression of PB1, PB2,
and NP, individually and in combination, was sufficient to inhibit
cellular interferon responses to either vRNA transfection orDNS1
infection (Figure 5D). This disruptive effect is more prominent for
PB1, PB2, and NP than for PA. This is consistent with the lower
enrichment of the PA neighborhoods across immune functions
and pathways and with the lower connectivity of PA in the PR8
and Udorn interaction networks (Figure 3D, Table 1). Taken
together, our results illustrate the functional relevance of the
Y2H interactions and implicate non-NS1 viral proteins modu-
lating host responses.
DISCUSSION
A Physical, Regulatory, and Functional Map
of Influenza-Host Interactions
Influenza-host interactions have evolved over countless infec-
tions across diverse host species. To capture this complex rela-1262 Cell 139, 1255–1267, December 24, 2009 ª2009 Elsevier Inc.tionship, we have constructed a first comprehensive map
representing the physical and regulatory interactions between
influenza virus and its primary human host cell. First, we assem-
bled a physical map of binary associations between human and
viral proteins. Second, we defined the regulatory responses of
the host using genome-wide mRNA profiling of HBECs exposed
to wild-type virus, DNS1 virus, viral RNA, or type I IFN. Third, we
overlaid these maps within the context of known cellular human
networks, expanding them to a neighborhood of the human
interaction network and annotated cellular pathways. This led
us to identify 1745 candidate genes that may play a role in influ-
enza replication or the host response to infection. To validate the
function of these candidate genes, we assessed the loss-of-
function effects of each of the candidates in three independent
in vivo assays in HBECs and classified each gene within a
specific phenocluster. These extensive experimental and com-
putational analyses allowed us to assign to each candidate
gene a physical, transcriptional, and phenotypic ‘‘fingerprint’’
that reflects its specialized role in the host-pathogen network
(Table S5).
Our results must be interpreted with care, and additional
experiments, such as in vivo pulldown assays during infection,
will be needed to further validate and refine the network. Further-
more, we conservatively scored our functional assays, and may
have masked relevant false negatives. Finally, analyses across
other influenza strains may further generalize our findings.
Nevertheless, by integrating across three sources of information,
we were able to reveal new roles for viral and host proteins in
manipulating the cellular machinery during infection.Effects of the NS1 Protein May Be Mediated by the p53
and WNT Pathways
We rediscoveredmany of the known roles and interactions of the
well-studied PR8 and Udorn NS1 proteins. For example, these
included NS1-dependent dampening (Figure 3A) of the RIG-I-
mediated transcriptional response to RNA (Pichlmair et al.,
2006) and the direct interaction between NS1 and proteins
involved in RIG-I/NFkB, PKR, and mRNA processing functions
(Figure 2B).
We also expanded the physical and regulatory scope of NS1
in the context of viral infection. We suggest a regulatory role
for NS1 in the induction of 45 RNA/IFN-independent VSRGs
(C8,12, Figure 3), 24 of which impact viral replication or the host
IFN response in our assays (Table S5). We found previously
unknown physical associations between NS1 and multiple
proteins of the p53 and WNT pathways (Figures 2B and 2C).
Components of these pathways affect the host response to virus
in our assays (Table S5), and direct treatment with recombinant
WNT protein increases cellular production of IFN in response to
vRNA and viral infection (Figures 5B and 5C). While further
experiments are required to understand the mechanistic basis
of these findings, we propose that NS1 protein has an even
broader impact on cellular processes thanwas previously appre-
ciated.A Potential Role for the Viral Polymerase
in Host-Pathogen Interactions
We discovered a large number of proteins and pathways,
including the NF-kB, p53, apoptosis, and WNT pathways, that
physically associate with the two viral polymerase subunits
PB1 and PB2, and with NP of the PR8 and Udorn strain (Figures
2B and 2C) pathways. In addition, these host components are
enriched in VSRGs, suggesting that the virus has also evolved
to indirectly regulate mRNA levels of genes in these networks.
Consistently, overexpression of one or more of the viral poly-
merase proteins (or NP) inhibits the IFN response to virus or
vRNA in epithelial cells. Further experiments, including disrup-
tion of individual virus-host protein interactions (e.g., PB2-
TRAF2 versus PB2-DVL3) through point mutations, are needed
to exclude nonspecific effects and to further establish these
mechanisms.Virus-Specific Regulated Genes Play an Important Role
in Host Defense
Transcriptional profiling of cells exposed to viruses or interme-
diate components of infection led us to discriminate a group of
genes (VSRGs, C6–8,11–12) that respond only to virus but not to
vRNA or IFN treatment. Many of these have not been previously
described in this context. VSRGs include major components of
the signaling pathways identified in the physical network, as
well as regulators of IFN production and viral replication
(Figure 3D, Table S5). How VSRGs are regulated and whether
they are specific to influenza virus or respond to a broader class
of viruses remains to be determined.CToward an Integrated Model of Host-Influenza
Interactions
To build a model of the core networks targeted by the virus
(Figure 6), we focused on the four main pathways identified in
our analysis as key targets of the virus both physically and tran-
scriptionally: NFkB (including RIGI and PKR), apoptosis, MAPK,
and WNT. We incorporated all the H1 proteins that directly asso-
ciate with these pathways into the model (see the Experimental
Procedures). We annotated each protein in the model with its
mode of regulation (physical or transcriptional), the specific viral
protein with which it associates, and the functional conse-
quences on IFN and replication upon its knockdown.
We find that the virus targets diverse signaling pathways by
affecting multiple components in each pathway through both
physical and regulatory interactions. While the same pathway
is often targeted by both mechanisms, the direct effect can be
mediated through distinct genes. This observation emphasizes
the virus’ capacity for combinatorial regulation of cellular pro-
cesses, and the importance of an integrated analysis approach
for revealing amore complete picture of the viral-human relation-
ship.
Many unrelated viruses (e.g., HSV, HIV, EBV, and KSHV; Table
S4 part B) also target the same proteins or pathways as influenza
(Brander and Walker, 2000; Hiscott et al., 2006). For example,
HIV targets NFKB1, p53, and b-catenin, and EBV targets
TRAF1/2 (Luftig et al., 2004) and SP100. Also consistent with
other viruses (Ko¨nig et al., 2008), perturbation of H1 proteins
does not typically result in a phenotypic change. Nevertheless,
for influenza, perturbation of a subset of the H1 proteins (e.g.,
TARBP2, BANP, STAU1, and PPP2R5C; see Figure 6) does
affect IFN production in response to vRNA, suggesting that the
virus may inhibit their function by direct binding. In addition,
based on the conservation of interactions across PR8 and
Udorn, it is likely that some of these extend to other influenza
viruses (e.g., the current H5N1, swine H1N1, and other
pathogenic strains) and represent candidates for therapeutic
targeting.
Our analysis identified the involvement of several pathways
whose role in the host response had not been fully appreciated.
For example, we found that a group of inflammasome-related
sensors are important in modulating IFN production (NLRP14,
NOD2, NLRP9, and NLRP10) and virus replication (NOD2). The
WNT, p53, ER stress, apoptosis, and PML pathways also impact
IFN and replication. Finally, we identified host proteins that were
not previously associated with influenza, each of which interacts
with multiple viral proteins and is essential for the control of PR8
viral replication (e.g., USHBP1, ZMAT4, and MAGEA11). Such
proteins are located at the host-pathogen interface and are likely
to mediate essential viral and host activities. Among these are
several RNA-binding proteins, whose function we validated in
an independent assay (Figure 5A).
With rapid advances in comprehensive measurement and
perturbation technologies, we will be able to produce increas-
ingly detailed maps of the physical and regulatory interactions
underlying viral-host relationships. Such models could provide
a basis for interrogating host circuitry across human individuals
to help identify host susceptibility factors and causal genetic
polymorphisms. Indeed, there is a significant overlap betweenell 139, 1255–1267, December 24, 2009 ª2009 Elsevier Inc. 1263
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Figure 6. An Integrated Model of the Key Signaling Pathways Modulated by Influenza-Host Interactions
For each host component within computationally selected pathways (see text), we show its mode of regulation and its functional role: (1) Direct physical contact
with viral proteins (small circles and diamonds); NS1 interactions with PKR, RIG-I, TRIM25 were added manually based on previous reports; (2) transcriptional
regulation in response to influenza infection in HBECs (increase in gene expression, thick red border; decrease, thick blue border); (3) transcriptional regulation by
the NS1 protein (open circle with inhibitory edge or activating edge); (4) role in modulation of IFN production or PR8 replication (filled, gray); or role only in the IFN
response to vRNA (filled, gradient). Txn, transcriptional. Influenza cofactor indicates significant change in PR8 replication upon siRNA knockdown of that gene.
vRNA response factor indicates a gene whose knockdown caused significant change only in the vRNA-induced interferon assay.the proteins in our model and the genes induced in patients
during influenza infection (data not shown). Comprehensive
models could also help explain differences in the host response
to influenza infection, when the virus is transmitted from one
species to another. While some physical and regulatory interac-
tions and their effects on cell function are likely conserved across
birds, pigs and humans, others may be host specific and could
help account for the differences in virulence across pathogenic
strains.EXPERIMENTAL PROCEDURES
Primary Cell Cultures and Virus Strains
Primary HBECs (Lonza, Basel, Switzerland) derived from normal human bron-
chial epithelium were maintained in vented T225 tissue culture flasks and
grown in bronchial epithelial cell basal medium (Lonza, Supplemental Data).
All experiments were performed with low passage (P) cells (P2–P5). Both
PR8 and DNS1 viral strains were grown in Vero cells (which allow efficient
growth of the DNS1 virus) in serum-free DMEM with 10% BSA and 1 mg/ml
TPCK trypsin. Viral titers were determined by standard MDCK plaque assays.1264 Cell 139, 1255–1267, December 24, 2009 ª2009 Elsevier Inc.Yeast Two-Hybrid Assays
Stringent Y2H assays were carried out as described (Venkatesan et al., 2009)
with open reading frames (ORFs) from PR8 and Udorn strains as DB-ORFs in
MATa Y8930 yeast and against the Human ORFeome v3.1 as AD prey in MATa
Y8800. Each primary screen was done twice, and all initial positive pairs from
the two primary screens were individually retested three times with fresh
stocks of DB-Flu and AD-Human yeast strains. The final data sets contain
those interaction pairs that successfully retested at least two times without
exhibiting autoactivation of the yeast HIS3 reporter gene (Rual et al., 2005;
Venkatesan et al., 2009).
Human Interaction Network
We generated a comprehensive human interaction network by combining
information from the interaction databases BioGRID, BIND, and INTACT. To
maximize coverage across the network, we included direct binary interactions,
cocomplexes, and protein modifications. In total, the network contained
57,206 interactions among 11,624 human proteins. To analyze the first neigh-
bors of H1 proteins (H2), we used both curated and noncurated resources.
Noncurated neighbors consisted of 1923 human proteins that physically
interact with H1 proteins based on the human interaction network. Curated
first neighbors consisted of 653 human proteins that interact directly with H1
proteins based on the Ingenuity Pathway Analysis (IPA) Interactions Knowl-
edge Base (Ingenuity, Redwood City, CA), when including only direct
relationships among proteins (i.e., excluding transcription regulation, protein-
DNA interactions and protein-chemical relations). The statistical analysis of
connection degrees around viral host proteins was calculated by permutation
testing (n = 10000). All reported p values for network connections were
adjusted for multiple testing with a false discovery rate (FDR) correction
(p < 0.05).
Functional Annotations
All gene lists for 36 functional categories were downloaded from the IPA data-
base. We also tested all 29 relevant categories specified by the GO Slim
generic list (Ashburner et al., 2000) and augmented it with an additional seven
immune-related Ingenuity categories. All p values for functional enrichments
were adjusted for multiple testing with an FDR correction (p < 0.05).
Pathway Analyses
We collected 646 cellular pathway gene sets, including the MSigDB (Subra-
manian et al., 2005) ‘‘canonical pathways’’ collection and viral-response
pathway gene sets from IPA. We grouped these into 212 distinct pathway
groups (Figure S7) to avoid redundancies. We tested whether the H1 proteins
and their curated first neighbors (H2), and each expression cluster was
overrepresented in the pathway gene set (a hypergeometric enrichment
test; the same result was obtained when using the noncurated H2 set,
Figure S8). All p values were adjusted for multiple testing with an FDR correc-
tion (p < 0.05).
mRNA Expression Profiling
HBECs were stimulated with a 15 min pulse of 1000 U/ml IFNb (PBL, Piscat-
away, NJ), 100 ng/ml vRNA (purified directly from PR8 virus) with LTX transfec-
tion reagent (Invitrogen, Carlsbad, CA), wild-type H1N1 influenza (A/PR/8/34),
or DNS1 virus (PR8 with a deleted NS1 gene, a gift from Dr. Garcia-Sastre).
Viruses were used at a multiplicity of infection (moi) of 5. Control samples
were incubated with media or LTX under the same conditions. Cells were
washed, supplemented with warm media, and harvested at 11 time points
(0, 0.25, 0.5, 1, 1.5, 2, 4, 6, 8, 12, and 18 hr posttreatment).
Array Hybridizations and Preprocessing
All array hybridizations and preprocessing were done with Affymetrix HT
Human Genome U133 Arrays (see the Supplemental Data). We defined the
fold change of each gene in a stimulated sample as the average intensity of
its probe set in two biological replicates, normalized by its expected intensity
at the same time point without treatment. To calculate the expected intensities,
genes were clustered based only on their intensities in the mock treatment
(PCluster [Segal et al., 2003], n = 30). For each time point, all genes within
a cluster were compared to the same expected intensities (i.e. the average
intensities of the particular mock time point across the entire cluster). To iden-
tify genes whose expression is affected by stimulation, we selected genes
with R1.6-fold change in two consecutive time points (or R2-fold for each
of the single time points, 12 hr or 18 hr) (Table S6). At this threshold, we expect
a 10% error rate, estimated by the number of genes that cross the cutoff in
mock LTX (false positives) versus vRNA+LTX transfection (true positives;
data not shown).
Clustering of Expression Data
We clustered the time-series gene expression data by a modification of the
PCluster algorithm. We first applied PCluster (k = 30) as previously described
(Segal et al., 2003) and then iteratively improved the partition. There are two
steps at each iteration: (1) splitting and (2) merging of clusters. The splitting
step learns the best partition of each cluster into two clusters, through a search
over every pair of consecutive time points. The query that best partitions the
gene expression at two consecutive time points into two distinct distributions
is chosen until no significant split exists (t test p value cutoff of 1023). In the
merging step, we merge pairs of clusters that are not significantly distinct in
any two consecutive time points (same t test cutoff). This fits our sparse
temporal information, when many genes are only regulated in a few consecu-
tive time points (e.g., C6,8). The 35 resulting clusters were grouped manually
into 12 categories called ‘‘expression clusters’’ (Figures 3A and 3B, C1–C12).CExpression cluster 1 (C1) includes those clusters that overlap but do not clearly
fall into any of these categories.
siRNA Transfection and Stimulation of Primary HBECs
HBECs (3.53 103, filtered through a 0.4 mm filter) were seeded in wells of trip-
licate 96-well plates. Twenty-four hours later, 25 nM (final concentration) of
siRNA duplexes (SMARTpools, Dharmacon) were transfected (HiPerFect,
QIAGEN) and incubated at 37C for 3 hr, followed by a media change. Cells
were incubated for 3 days with one media change at 24 hr posttransfection.
After knockdown, we used AlamarBlue (Invitrogen, Carlsbad, CA) to determine
live cell numbers in all wells (in some replicate plates). Cells were then washed
twice with complete media. To assess the effects of siRNAs on influenza virus
replication, cells were inoculated with PR8 virus at a moi of 1. At 48 hr postin-
fection, HBEC supernatants were harvested and frozen with 5 mg/ml TPCK
trypsin. To assess effects on IFN production in response to vRNA and
DNS1, cells were transfected with 100 ng/ml vRNA or infected with DNS1virus
at amoi 5. At 24 hr posttransfection or infection, HBEC supernatants were har-
vested for IFN assays.
Virus Titering of HBEC Supernatant
293T cells (2 3 106, filtered through a 0.4 mm filter) were seeded in 10 cm
dishes and transfected with a vRNA luciferase reporter plasmid based on prior
design (Lutz et al., 2005) with Transit-LT1. Cells were trypsinized at 24 hr
posttransfection and 104 transfected reporter cells were reseeded in white
Costar plates. Supernatants (frozen with trypsin) from PR8-infected HBECs
were added to reporter cells and incubated for 24 hr. Reporter activity was
measured with firefly luciferase substrate (Steady-Glo, Promega, Madison,
WI). Luminescence in 96-well plates was quantifiedwith the EnvisionMultilabel
reader (Perkin Elmer, Waltham, MA) fitted with an automated plate stacker.
Determining Interferon Production from HBEC Supernatants
Cells were infected with a lentivirus containing ISRE-luciferase (Cignal Lenti
ISRE Reporter, SA Biosystems, Frederick, MD). After selection with puro-
mycin, stably infected cells were cloned by limiting dilution and tested for
responsiveness to human IFNb (PBL, Piscataway, NJ). A clone with high signal
to background ratio was selected and found to be sensitive to low levels of
IFNb (<1 U/ml) with a >1003 dynamic range. Fro measurement of IFNb in
supernatants from experimental assays, ISRE-Luc reporter cells were seeded
in flat bottom white Costar plates at 2 3 104/well. Twenty-four hours later,
supernatants were added and assayed for ISRE-Luc-inducing activity with
firefly luciferase substrate.
Scoring of Functional Assays and Identification of Phenoclusters
For each assay, luminescence values were quantified with the Envision
reader for ISRE-luc and vRNA-luc reporters. These values were normalized
with robust Z score normalization (RNAeyes program, A. Derr, Broad Insti-
tute) and averaged across three replicates. Robust Z scores were further
normalized to cell number per well by calculating the distance of each robust
Z score from the running average of robust Z scores versus AlamarBlue
values. These cell number-normalized Z scores, referred to as phenotype
scores, reduce the impact of cell number variation on assay measurements
and allow comparisons across wells and plates. Genes with a phenotype
score equivalent to a 2-fold or more change in IFN or replication (compared
to the median score for the relevant assay; see the Supplemental Data) in
each assay were analyzed further and clustered into 20 ‘‘phenoclusters’’
with single-linkage hierarchical clustering with the Cluster software (Eisen
et al., 1998). Statistical enrichments of phenotype scores in expression
clusters or pathway gene sets were evaluated by permutation tests (n =
10,000).
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cgi?acc=GSE19392).ell 139, 1255–1267, December 24, 2009 ª2009 Elsevier Inc. 1265
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, eight
figures, and six tables and can be found with this article online at http://
www.cell.com/supplemental/S0092-8674(09)01565-7.
ACKNOWLEDGMENTS
We thank D. Lieber and K. Maciag for discussions and help with data analysis.
We thank C. Shamu and S. Chiang at ICCB (HMS) for the siRNA library and
expert advice, S. Gupta and the Broad’s Genetic Analysis Platform for micro-
array processing, H. Le, A. Derr, B. Wong, and the staff at the Broad RNAi Plat-
form for assistance with RNAi studies and analysis, L. Wu for the vRNA
reporter plasmid, R. Cadagan and A. Garcia-Sastre for DNS1 virus, E. Fodor
for PR8 plasmids, R. Lamb for Udorn plasmids, and S. Hart for assistance
with artwork. This work was supported by National Institutes of Health (NIH)
grant U01 AI074575 (N.H., D.R., and D.H.); U54 AI057159 and the NIH New
Innovator Award (N.H.); Ford Foundation Predoctoral Fellowship (M.G.);
EMBOPostdoctoral Fellowship (I.G.V.); The Ellison Foundation andNIH grants
R01 HG001715 and P50 HG004233 (D.H.); and the Howard Hughes Medical
Institute, a Career Award at the Scientific Interface from the Burroughs Well-
come Fund, the NIH Pioneer Award, and the Sloan Foundation (A.R.).
Received: December 2, 2009
Revised: December 9, 2009
Accepted: December 9, 2009
Published online: December 17, 2009
REFERENCES
Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M.,
Davis, A.P., Dolinski, K., Dwight, S.S., Eppig, J.T., et al., The Gene Ontology
Consortium. (2000). Gene ontology: tool for the unification of biology. Nat.
Genet. 25, 25–29.
Bailer, S.M., and Haas, J. (2009). Connecting viral with cellular interactomes.
Curr. Opin. Microbiol. 12, 453–459.
Brander, C., and Walker, B.D. (2000). Modulation of host immune responses
by clinically relevant human DNA and RNA viruses. Curr. Opin. Microbiol. 3,
379–386.
Brass, A.L., Dykxhoorn, D.M., Benita, Y., Yan, N., Engelman, A., Xavier, R.J.,
Lieberman, J., and Elledge, S.J. (2008). Identification of host proteins required
for HIV infection through a functional genomic screen. Science 319, 921–926.
Bushman, F.D., Malani, N., Fernandes, J., D’Orso, I., Cagney, G., Diamond,
T.L., Zhou, H., Hazuda, D.J., Espeseth, A.S., Ko¨nig, R., et al. (2009). Host
cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS
Pathog. 5, e1000437.
Eisen, M.B., Spellman, P.T., Brown, P.O., and Botstein, D. (1998). Cluster anal-
ysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci.
USA 95, 14863–14868.
Everett, R.D., and Chelbi-Alix, M.K. (2007). PML and PML nuclear bodies:
implications in antiviral defence. Biochimie 89, 819–830.
Gack, M.U., Albrecht, R.A., Urano, T., Inn, K.S., Huang, I.C., Carnero, E., Far-
zan, M., Inoue, S., Jung, J.U., and Garcı´a-Sastre, A. (2009). Influenza A virus
NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral
RNA sensor RIG-I. Cell Host Microbe 5, 439–449.
Garcia, J.A., Ou, S.H., Wu, F., Lusis, A.J., Sparkes, R.S., and Gaynor, R.B.
(1992). Cloning and chromosomal mapping of a human immunodeficiency
virus 1 ‘‘TATA’’ element modulatory factor. Proc. Natl. Acad. Sci. USA 89,
9372–9376.
Hale, B.G., Randall, R.E., Ortı´n, J., and Jackson, D. (2008). The multifunctional
NS1 protein of influenza A viruses. J. Gen. Virol. 89, 2359–2376.
Hao, L., Sakurai, A., Watanabe, T., Sorensen, E., Nidom, C.A., Newton, M.A.,
Ahlquist, P., and Kawaoka, Y. (2008). Drosophila RNAi screen identifies host
genes important for influenza virus replication. Nature 454, 890–893.1266 Cell 139, 1255–1267, December 24, 2009 ª2009 Elsevier Inc.Hayward, S.D., Liu, J., and Fujimuro, M. (2006). Notch and Wnt signaling:
mimicry and manipulation by gamma herpesviruses. Sci. STKE 2006, re4.
Hiscott, J., Nguyen, T.L., Arguello, M., Nakhaei, P., and Paz, S. (2006). Manip-
ulation of the nuclear factor-kappaB pathway and the innate immune response
by viruses. Oncogene 25, 6844–6867.
Ko¨nig, R., Zhou, Y., Elleder, D., Diamond, T.L., Bonamy, G.M., Irelan, J.T.,
Chiang, C.Y., Tu, B.P., De Jesus, P.D., Lilley, C.E., et al. (2008). Global analysis
of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell
135, 49–60.
Krishnan, M.N., Ng, A., Sukumaran, B., Gilfoy, F.D., Uchil, P.D., Sultana, H.,
Brass, A.L., Adametz, R., Tsui, M., Qian, F., et al. (2008). RNA interference
screen for human genes associated with West Nile virus infection. Nature
455, 242–245.
Krug, R.M., Yuan, W., Noah, D.L., and Latham, A.G. (2003). Intracellular
warfare between human influenza viruses and human cells: the roles of the viral
NS1 protein. Virology 309, 181–189.
Lamesch, P., Li, N., Milstein, S., Fan, C., Hao, T., Szabo, G., Hu, Z., Venkate-
san, K., Bethel, G., Martin, P., et al. (2007). hORFeome v3.1: a resource of
human open reading frames representing over 10,000 human genes. Geno-
mics 89, 307–315.
Li, S., Min, J.Y., Krug, R.M., and Sen, G.C. (2006). Binding of the influenza A
virus NS1 protein to PKR mediates the inhibition of its activation by either
PACT or double-stranded RNA. Virology 349, 13–21.
Li, Q., Brass, A.L., Ng, A., Hu, Z., Xavier, R.J., Liang, T.J., and Elledge, S.J.
(2009). A genome-wide genetic screen for host factors required for hepatitis
C virus propagation. Proc. Natl. Acad. Sci. USA 106, 16410–16415.
Luftig, M., Yasui, T., Soni, V., Kang, M.S., Jacobson, N., Cahir-McFarland, E.,
Seed, B., and Kieff, E. (2004). Epstein-Barr virus latent infection membrane
protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical
NF-kappaB activation. Proc. Natl. Acad. Sci. USA 101, 141–146.
Lutz, A., Dyall, J., Olivo, P.D., and Pekosz, A. (2005). Virus-inducible reporter
genes as a tool for detecting and quantifying influenza A virus replication.
J. Virol. Methods 126, 13–20.
Patel, R.C., Vestal, D.J., Xu, Z., Bandyopadhyay, S., Guo, W., Erme, S.M., Wil-
liams, B.R., and Sen, G.C. (1999). DRBP76, a double-stranded RNA-binding
nuclear protein, is phosphorylated by the interferon-induced protein kinase,
PKR. J. Biol. Chem. 274, 20432–20437.
Pichlmair, A., Schulz, O., Tan, C.P., Na¨slund, T.I., Liljestro¨m, P., Weber, F., and
Reis e Sousa, C. (2006). RIG-I-mediated antiviral responses to single-stranded
RNA bearing 50-phosphates. Science 314, 997–1001.
Reichman, T.W., Parrott, A.M., Fierro-Monti, I., Caron, D.J., Kao, P.N., Lee,
C.G., Li, H., and Mathews, M.B. (2003). Selective regulation of gene expres-
sion by nuclear factor 110, a member of the NF90 family of double-stranded
RNA-binding proteins. J. Mol. Biol. 332, 85–98.
Rual, J.F., Venkatesan, K., Hao, T., Hirozane-Kishikawa, T., Dricot, A., Li, N.,
Berriz, G.F., Gibbons, F.D., Dreze, M., Ayivi-Guedehoussou, N., et al. (2005).
Towards a proteome-scale map of the human protein-protein interaction
network. Nature 437, 1173–1178.
Sabbah, A., Chang, T.H., Harnack, R., Frohlich, V., Tominaga, K., Dube, P.H.,
Xiang, Y., and Bose, S. (2009). Activation of innate immune antiviral responses
by Nod2. Nat. Immunol. 10, 1073–1080.
Satterly, N., Tsai, P.L., van Deursen, J., Nussenzveig, D.R., Wang, Y., Faria,
P.A., Levay, A., Levy, D.E., and Fontoura, B.M. (2007). Influenza virus targets
the mRNA export machinery and the nuclear pore complex. Proc. Natl.
Acad. Sci. USA 104, 1853–1858.
Segal, E., Shapira, M., Regev, A., Pe’er, D., Botstein, D., Koller, D., and Fried-
man, N. (2003). Module networks: identifying regulatory modules and their
condition-specific regulators from gene expression data. Nat. Genet. 34,
166–176.
Staal, F.J., Luis, T.C., and Tiemessen, M.M. (2008). WNT signalling in the
immune system: WNT is spreading its wings. Nat. Rev. Immunol. 8, 581–593.
Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gil-
lette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S., and
Mesirov, J.P. (2005). Gene set enrichment analysis: a knowledge-based
approach for interpreting genome-wide expression profiles. Proc. Natl.
Acad. Sci. USA 102, 15545–15550.
Takeuchi, O., and Akira, S. (2009). Innate immunity to virus infection. Immunol.
Rev. 227, 75–86.
Turpin, E., Luke, K., Jones, J., Tumpey, T., Konan, K., and Schultz-Cherry, S.
(2005). Influenza virus infection increases p53 activity: role of p53 in cell death
and viral replication. J. Virol. 79, 8802–8811.CVenkatesan, K., Rual, J.F., Vazquez, A., Stelzl, U., Lemmens, I., Hirozane-
Kishikawa, T., Hao, T., Zenkner, M., Xin, X., Goh, K.I., et al. (2009).
An empirical framework for binary interactome mapping. Nat. Methods 6,
83–90.
Wressnigg, N., Shurygina, A.P., Wolff, T., Redlberger-Fritz, M., Popow-
Kraupp, T., Muster, T., Egorov, A., and Kittel, C. (2009). Influenza B mutant
viruses with truncated NS1 proteins grow efficiently in Vero cells and are
immunogenic in mice. J. Gen. Virol. 90, 366–374.ell 139, 1255–1267, December 24, 2009 ª2009 Elsevier Inc. 1267
